$16 M

IBIO Mkt cap, 15-Oct-2018

$444 K

iBio Revenue FY, 2018
iBio EBIT (FY, 2018)-14.2 M
iBio Cash, 30-Jun-201815.9 M

iBio Revenue Breakdown

Embed Graph

iBio revenue breakdown by geographic segment: 100.0% from United States and 0.0% from Other

iBio Income Statement

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2018

Revenue

205.0k1.9m948.0k444.0k

Revenue growth, %

803%(49%)

R&D expense

1.9m3.5m3.2m

General and administrative expense

3.9m5.0m7.7m10.7m

Operating expense total

5.8m8.5m10.8m14.7m

EBIT

(3.8m)(6.7m)(9.9m)(14.2m)

EBIT margin, %

(1873%)(360%)(1044%)(3204%)

Interest expense

807.0k1.9m

Interest income

8.0k9.0k22.0k15.0k

Net Income

(3.7m)(6.6m)(10.7m)

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q3, 2018

Revenue

819.0k349.0k160.0k134.0k379.0k135.0k75.0k37.0k353.0k

R&D expense

552.0k585.0k343.0k1.2m815.0k551.0k704.0k1.0m

General and administrative expense

949.0k1.1m951.0k1.1m1.2m1.4m1.7m2.4m2.5m2.4m2.8m7.7m

Operating expense total

(240.0k)1.6m1.3m2.2m2.0m2.0m2.4m3.5m3.3m3.4m4.0m10.6m

EBIT

240.0k(1.6m)(1.3m)(1.4m)(1.7m)(1.8m)(2.3m)(3.1m)(3.2m)(3.3m)(3.9m)(10.3m)

EBIT margin, %

(173%)(484%)(1133%)(1682%)(811%)(2336%)(4433%)(10638%)(2912%)

Interest expense

323.0k483.0k483.0k481.0k1.4m

Interest income

2.0k2.0k3.0k1.0k2.0k2.0k2.0k5.0k13.0k12.0k8.0k13.0k

Net Income

379.0k(1.6m)(1.3m)(1.4m)(1.7m)(1.8m)(2.2m)(3.6m)

iBio Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2018

Cash

3.6m9.5m23.0m15.9m

Inventories

118.0k182.0k264.0k

Current Assets

3.9m10.1m23.9m16.3m

PP&E

6.0k13.0k25.6m25.2m

Total Assets

6.5m12.5m51.6m43.1m

Accounts Payable

297.0k1.1m1.2m790.0k

Current Liabilities

2.3m2.0m

Total Liabilities

27.6m26.9m

Additional Paid-in Capital

47.2m59.0m67.5m104.4m

Retained Earnings

(41.2m)(47.8m)(57.6m)(88.2m)

Total Equity

6.1m11.2m24.0m16.2m

Financial Leverage

1.1 x1.1 x2.1 x2.7 x

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q3, 2018

Cash

3.4m5.7m4.3m3.5m8.1m8.4m6.7m21.9m20.1m16.3m12.4m3.4m

Current Assets

4.6m6.9m5.5m4.1m9.0m9.1m7.2m22.7m20.5m16.7m13.0m4.0m

PP&E

5.0k7.0k20.0k14.0k10.0k14.0k25.8m25.6m25.5m25.8m25.3m

Total Assets

7.3m9.6m8.2m6.7m11.4m11.4m9.4m50.7m48.1m44.2m40.7m31.0m

Accounts Payable

1.3m1.2m1.1m516.0k815.0k1.3m1.6m979.0k731.0k1.4m939.0k

Current Liabilities

1.2m2.4m2.2m1.9m2.6m1.9m

Total Liabilities

1.7m1.7m1.2m1.2m1.3m1.6m1.5m27.7m27.4m27.0m27.8m26.9m

Additional Paid-in Capital

42.8m46.2m47.0m48.0m56.1m59.4m59.7m63.1m67.7m68.0m80.7m87.9m

Retained Earnings

(37.2m)(38.8m)(40.1m)(42.6m)(45.9m)(49.6m)(51.9m)(54.9m)(60.7m)(63.9m)(67.8m)(83.8m)

Total Equity

7.0m5.4m10.2m9.8m7.9m22.9m20.7m17.1m12.9m4.2m

Financial Leverage

1.2 x1.2 x1.1 x1.2 x1.2 x2.2 x2.3 x2.6 x3.1 x7.5 x

iBio Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2018

Net Income

(3.7m)(6.6m)(10.7m)

Depreciation and Amortization

361.0k363.0k940.0k1.7m

Inventories

97.0k(64.0k)(82.0k)

Accounts Payable

56.0k806.0k(125.0k)49.0k

Cash From Operating Activities

(4.1m)(4.7m)(8.1m)(13.5m)

Cash From Investing Activities

(259.0k)(215.0k)(68.0k)(1.1m)

Long-term Borrowings

(183.0k)

Cash From Financing Activities

3.6m10.9m21.7m22.4m

Interest Paid

485.0k1.9m

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q3, 2018

Net Income

379.0k(1.6m)(1.3m)(1.4m)(1.7m)(1.8m)(4.1m)(3.6m)

Depreciation and Amortization

92.0k184.0k537.0k412.0k826.0k1.3m1.3m

Accounts Payable

1.1m516.0k815.0k171.0k190.0k342.0k53.0k(255.0k)7.0k102.0k

Cash From Operating Activities

(1.1m)(2.8m)(5.2m)(2.3m)(5.8m)(9.4m)(10.1m)

Cash From Investing Activities

(18.0k)(5.0k)(8.0k)(602.0k)(765.0k)(1.1m)(797.0k)

Long-term Borrowings

(136.0k)

Cash From Financing Activities

63.0k63.0k17.7m(41.0k)(83.0k)(126.0k)6.2m

Interest Paid

484.0k966.0k1.4m1.4m

iBio Ratios

USDY, 2018

Revenue/Employee

10.3k

Financial Leverage

2.7 x
Report incorrect company information

iBio Operating Metrics

FY, 2016

Patents Issued

67

Patents Pending

19
Report incorrect company information